Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IVDN: Our R-6 Rated Insultex House Wrap (TM) meets or exceeds the standards in new building codes taking effect in 2024. A patented evacuated cell design outperforms all competitive products for energy efficiency. Plus, we add a moisture barrier. Visit: http://insultexhousewrap.com
$CATV huge news this week. Category V Biotech, Inc. Announces Exclusive Licensing Of Genetic Networks’ Intellectual Property For Cannabis Applications https://catvbt.com/category-v-biotech-inc-announces-exclusive-licensing-of-genetic-networks-intellectual-property-for-cannabis-applications/ #cannabis #rights #licensing #uplist #nasdaq
$GTVH Golden Triangle Ventures Announces Replay of CEO Steffan Dalsgaard's Comprehensive Spaces Event on X.com
https://finance.yahoo.com/news/golden-triangle-ventures-announces-replay-123000865.html
$CYCA CEO Gary Campbell discusses updates on development of IGAN 2.0 and future of Cytta Corp
$AVRW: Interview with Nancy Duitch, CEO Avenir Wellness Solutions (OTC: AVRW)
May 3, 2024
Nancy Duitch serves as the CEO of Avenir Wellness Solutions. With over three decades of experience in the consumer products sector, Nancy has cultivated a diverse array of businesses, guiding them from inception to the public market. Her expertise extends to orchestrating cutting-edge marketing and branding initiatives, resulting in a staggering $3 billion in revenue for esteemed brands. From her early years, Nancy exhibited a clear vision and pursued it with determination. Her knack for crafting iconic brands for infomercials and direct-to-consumer channels has solidified her position as one of the most sought-after female CEOs in the industry. Join us as we delve into Nancy's journey, experiencing her infectious energy and enthusiasm as a lifelong entrepreneur who truly lives life to the fullest.
$AVRW Solid Growth Reported for Seratopical Revolutions Skin Care Line with Boost from Famed Beauty Box FabFitFun and Endorsements from Key Celebrities, Influencers and Top Medical Professionals: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW) https://www.einpresswire.com/article/711238053/solid-growth-for-seratopical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
$IVDN Low Float of 16 million is on track for a record sales and revenue growth year in 2024, as detailed in official company news below. IVDN management is making steady progress to grow market share and also protect the very valuable patent rights of its unique Insultex product line which is the only evacuated cell insulation on the market with energy saving performance that no competitor can match.
IVDN is now starting to see accelerating sales success as word is spreading about Insultex House Wrap as described on the dedicated website at http://www.insultexhousewrap.com. Add to this advantage, the fact that the IVDN product meets or exceeds new building codes going into effect this year requiring continuous insulation while competitors are failing this critical criteria. www.InsultexHouseWrap.com
Innovative Designs Vendor Growth
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html
$CATV NEWS: Category V Biotech, Inc. Announces Exclusive Licensing of Genetic Networks' Intellectual Property for Cannabis Applications
FLORIDA, July 2, 2024 – Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC (https://geneticnetworks.com/).
https://www.otcmarkets.com/stock/CATV/news/CATV-signs-Exclusive-Licensing-Deal-with-Genetic-Networks-for-Cannabis-Research?id=445565
$GRNF GRN Holding Corporation, is proud to announce its strategic rebranding to Marijuana Inc
*Donald Steinberg: Recognized as the "Henry Ford of the Marijuana Industry.”
https://finance.yahoo.com/news/grn-holding-corporation-announces-rebranding-120000766.html
$CATV .0016 HOD .00175 #OTC #Mondaymover
$CYCA Stay Up to Date with The Weekly Cytta Corp Newsletter & Webcast
Sign up here: https://cytta.com/investors/
$IVDN Sales for the first 5 months of 2024 approached 90% of last year's total.
#sales #revenue #growth #contractors #insulation
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html #OTCQB
$AVRW How To Choose The Best Products For You https://seralabshealth.com/blogs/blog/seratopical-revolution-vs-naked-thriving-similarities-differences-how-to-choose-the-best-products-for-you
@SeralabsHealth @AvenirWellness #OTCQB
$CATV - #OTC #portfolio (Stock Symbol: CATV) Great NEWS! "Favorable Federal Reclassification of Specialty Botanical Unlocks Major Opportunity for Genetics Tech Acquisition-Oriented Pharmaceutical Developer via Category V Biotech, Inc." https://www.einpresswire.com/article/714358251/favorable-federal-reclassification-of-specialty-botanical-products-unlocks-major-opportunity-for-acquisition-otc-catv
$APVO $SXTC $HOLO $VVPR $LGVN $CYCC $HKD $TSLA
Good morning. $CYCA Closed the week strong 0.029 (+20.8333%) At close: June 28 12:24PM EDT #huge move expected. www.cytta.com #OTCQB #Nasdaq mover More Movers: $NVDA $AMC $GME
$AVRW +38.70% in last 90 days: Detailed quote: https://ih.advfn.com/stock-market/USOTC/avenir-wellness-solutions-qb-AVRW/stock-price
$CCTG - CCSC Technology International Holdings Limited Enters into International Purchase Agreement with SHI / LIGHTCARE-SOLUTIONS ApS @nasdaq https://finance.yahoo.com/news/ccsc-technology-international-holdings-limited-123000972.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance $GOVX $RIVN $CCL $VIGL $MLGO $T $BTBT $MSFT $SMR $PANW $SHOT #NEWS
$NRXP News: NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 2024, based on two positive trials 1 2 and Breakthrough Therapy Designation. Potential revenue in 2025
NDA for NRX-100 (IV ketamine) in suicidal depression in advanced preparation for submission in 2024; based on four positive trials 3 4 5 6 and Fast Track Designation. Potential revenue in 2025
Gaining these approvals has the potential to yield more than $150 in revenue per NRXP share in the near term, at current share count
Planning for HOPE Therapeutics share distribution progresses; audit nearing completion – critical step towards a public listing
RADNOR, Pa., June 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that advice from regulatory counsel, which includes former senior officials from the Food and Drug Administration, supports filing two New Drug Applications (NDAs) in 2024: an application for Accelerated Approval for NRX-101 to treat bipolar depression in patients with akathisia and an application for approval of NRX-100 (IV ketamine) for treatment of suicidal depression.
(PRNewsfoto/NRx Pharmaceuticals)
(PRNewsfoto/NRx Pharmaceuticals)
While efficacy and safety data are now in hand, filing of the above applications is dependent upon completion of 12-month stability data in manufactured lots as required by FDA regulations.
As disclosed in an 8K filing, NRx will be filing the NRX-101 application without a commercial partner. The addressable market for the accelerated approval indication is such that a compact and efficient salesforce can be constructed by a small company, such as NRx, and current executives at NRx have previously held primary responsibility for launch of similar-sized pharmaceutical assets.
NRx continues work to enable the distribution of shares in Hope Therapeutics. This distribution is dependent upon completion of a public audit and successful review of an SEC Form 10.
"The NRx team has worked diligently since the end of the COVID pandemic to achieve these milestones for our shareholders and most importantly the patients we have always sought to help," said Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx. "Given the near-term market opportunity represented by an accelerated approval process, NRx anticipates a higher potential return to NRx investors associated with an NRx-led initiative than that which would likely be achieved with a large commercial partner."
NRX-101 for Bipolar Depression
NRX-101 is the Company's patented (Composition of Matter), oral combination of the NMDA antagonist D-cycloserine and lurasidone for bipolar depression. Data from two active control clinical trials vs. the standard of care, lurasidone, have shown comparable antidepressant efficacy with clinically important reductions in suicidality and/or akathisia. To the Company's knowledge, no other oral agent has demonstrated such a valuable profile.
Up to 15% of people treated with drugs in lurasidone's class develop akathisia7; this would constitute an estimated $3.7 billion initial market for NRX-101, with no approved medicines for akathisia. This is a population the Company can readily address without a large commercial partner, given the relatively small number of psychiatrists who treat high-risk patients. The broad bipolar market constitutes 7 million people and an opportunity greater than $20 billion per year. With a best-in-class product profile, the Company projects NRX-101 sales in excess of $2 billion.
NRX-101 was awarded Breakthrough Therapy Designation, Fast Track Designation, a Biomarker Letter of Support, and a Special Protocol Agreement by the FDA for treatment of suicidal bipolar depression.
NRX-100 (IV ketamine) for Suicidal Depression
Intravenous ketamine is widely accepted as a standard of care for acute treatment of suicidal depression, in the absence of an FDA-labeled product; the only treatment currently approved by FDA is electroconvulsive therapy (ECT).
According to the CDC, 3.5 million Americans make a plan for suicide each year.8 This represents a $3-5 billion market at expected pricing.
Based on the data in the trials referenced above, the Company's regulatory counsel has encouraged the Company to file an NDA for suicidal depression for NRX-100. This application has been in development and awaits 12-month stability data for filing, which is expected in 2024.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreements. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
1 Nierenberg A, Lavin P, Javitt DC, et. al. NRX-101 vs lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior; a randomized prospective phase 2 trial. Int J Bipolar Dis 2023;11:28-38, STABIL-B
2 Nierenberg, et. al., A Randomized, Double-Blind Controlled Comparison of NRX-101 (D-cycloserine/lurasidone) to Lurasidone for Adults with Bipolar Depression and Subacute Suicidal Ideation or Behavior. Am Soc Clin Psych Annual Meeting 2024. ASCP Poster
3 Fava, M et. al., Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) Mol Psychiatry. 2020; 25(7): 1592–1603.
4 Grunebaum, et. al., Ketamine for Rapid Reduction of Suicidal Thoughts. Am J Psychiatry. 2018 Apr 1: 175(4): 327-335
5 Abbar, et. al. Ketamine for Acute Treatment of Severe Suicidal Ideation, BMJ 2022; 376
6 Anand, et. al, Ketamine is non-inferior to ECT for non-psychotic treatment resistant depression. NEJM 2023 388(25):2315-2325
7 Chow, C, et. Al., Akathisia and Newer Second-Generation Antipsychotic Drugs: A Review of Current Evidence
Pharmacotherapy 2020;40(6):565–574
8 CDC Suicide Data.
HOPE Therapeutics, Inc. (PRNewsfoto/NRx Pharmaceuticals, Inc.)
HOPE Therapeutics, Inc. (PRNewsfoto/NRx Pharmaceuticals, Inc.)
CisionCision
Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-to-proceed-with-two-new-drug-applications-in-2024-nrx-101-has-been-returned-to-the-company-for-filing-302185390.html
SOURCE NRx Pharmaceuticals, Inc.
$SHOT NEWS: President Jordan Schur Invests $1M in the Company Through his Family Fund, Core 4 Capital Corp.
Safety Shot, Inc. -Fri, Jun 28, 2024, 8:30 AM EDT
In this article: SHOT +4.95%
https://finance.yahoo.com/news/safety-shot-president-jordan-schur-123000162.html
$SHOT (Nasdaq: SHOT) "Professional Boxer and Social Media Sensation
@RyanGarcia Joins Safety Shot as Brand Ambassador"
Follow $SHOT on Twitter @drinksafetyshot
Link: https://globenewswire.com/en/news-release/2024/06/24/2902986/0/en/Professional-Boxer-and-Social-Media-Sensation-Ryan-Garcia-Joins-Safety-Shot-as-Brand-Ambassador.html
$CYCA @CyttaCorp Advances School Safety and Law Enforcement Tech with FIZUAS Partnership : Cytta Corp (Stock Symbol: CYCA) ; Partnership with FIZUAS Supporting Drone and Advanced Streaming Tech Solutions https://www.einpresswire.com/article/722643501/cytta-corp-and-fizuas-team-up-to-enhance-drone-and-streaming-tech-for-law-enforcement-cytta-corp-stock-symbol-cyca
$AVRW Avenir Wellness Solutions™ AVRW Skin Care and Nutraceutical Products are Available at Major Retailers Including Amazon $AMZN Walmart $WMT Target $TGT and CVS Health $CVS
For more info on Avenir Wellness $AVRW www.avenirwellness.com / www.Seralabshealth.com
$CATV (Stock Symbol: CATV) Favorable Federal Reclassification of Specialty Botanical Unlocks Major Opportunity for Genetics Tech Acquisition-Oriented Pharmaceutical Developer via Category V Biotech, Inc. https://www.einpresswire.com/article/714358251/favorable-federal-reclassification-of-specialty-botanical-products-unlocks-major-opportunity-for-acquisition-otc-catv
$APVO $SXTC $HOLO $VVPR $LGVN $CYCC $HKD $TSLA
$AVRW Article out via InStyle Magazine, "Nicole Kidman Just Turned 57, and I’m Buying Her 5 Go-To Beauty Products" via #SeralabsHealth https://www.instyle.com/nicole-kidman-birthday-favorite-beauty-products-8666305?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons #OTCQB @AvenirWellness #celebrity #spokesperson
$CCTG - CCSC Technology capabilities include: Turn-key service of manufacturing complex cable & wire harness assemblies https://ccsc-interconnect.com/html/aboutus/capabilities/
$AAPL $META $NTES $NET $PCQ $ZTS $TMDX $BDX $IFF $BCA $WFC $INTR $FITB $NYCB $BANF $HBAN $INDB $GGAL $LYC
$IVDN on Seekingalpha.com- Innovative Designs Vendor Growth https://seekingalpha.com/pr/19683617-innovative-designs-vendor-growth?source=tweet @SeekingAlpha
$CATV Expecting more news on upon company merger.
https://finance.yahoo.com/news/category-v-biotech-inc-announces-133800196.html
$CCTG (Nasdaq: CCTG) CCSC's European Supply Chain Center to Enhance Global Growth of Interconnected Products Needed in a Wide Range of Industries: CCSC Technology International Holdings Limited https://www.einpresswire.com/article/711804425/new-european-supply-chain-center-to-enhance-global-growth-of-interconnected-products-for-many-industries-nasdaq-cctg via @ein_new
$SHOT Nasdaq #BreakingNews #RyanGarcia Joins the Company's Tribe of Creators, Athletes and Music Artists to Bring the Revolutionary Beverage to the Masses! $MNST $JD $MSTR $HIMS Safety Shot
Ryan Garcia X Safety Shot ⚡ LFG pic.twitter.com/rcg8fcI8dw
— Safety Shot (@drinksafetyshot) June 24, 2024
$CYCA #OTCQB New Partnership with FIZUAS - Supporting #Drone and Advanced #Streaming Tech Solutions for Rising Demand by Numerous Law Enforcement Agencies; #CyttaCARES Offering a Valuable Solution for the School Safety Crisis: @CyttaCorp https://www.einpresswire.com/article/722643501/cytta-corp-and-fizuas-team-up-to-enhance-drone-and-streaming-tech-for-law-enforcement-cytta-corp-stock-symbol-cyca $DRO $AVAV $AMZN
$CATV .0019 +11.76% More eyes on us this week.
$AVRW "Nicole Kidman Just Turned 57, and I’m Buying Her 5 Go-To Beauty Products" via #SeralabsHealth https://www.instyle.com/nicole-kidman-birthday-favorite-beauty-products-8666305?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons #OTCQB @AvenirWellness
$SHOT More News! Safety Shot Partners with Atlantic Beverage Distributors to Expand Distribution Into Massachusetts and Rhode Island; This Partnership Marks the Next Step in the Company's Expansion Plan in the Northeast https://www.prnewswire.com/news-releases/safety-shot-partners-with-atlantic-beverage-distributors-to-expand-distribution-into-massachusetts-and-rhode-island-302182596.html #NEWS #energydrinks
$RENB - Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection - NVIDIA (NASDAQ:NVDA)
https://www.benzinga.com/partner/biotech/24/05/38641138/renovaro-inc-nasdaq-renb-aims-to-revolutionize-cancer-detection-and-treatment-using-multi-cancer- Benzinga #Healthcare #Biopharma $NVDA #AI #Computing #Power
$CCTG #Nasdaq Latest Article Out as CCSC Technology to Establish European Supply Chain Center Amid New AI and Healthcare Lighting Agreements: CCSC Technology (Nasdaq: CCTG) https://t.co/NenkPRwiaA
$CATV #Lotto play on alert for more news on company merger.
https://finance.yahoo.com/news/category-v-biotech-inc-announces-133800196.html
$SHOT NEWS: Safety Shot Announces Strategic Partnership with Chip Quigley and Ari Freedman
Safety Shot, Inc.
Tue, Jun 25, 2024, 8:45 AM EDT
In this article: SHOT +8.57%
Safety Shot, Inc.
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution
JUPITER, FL, June 25, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) proudly announces today a strategic partnership with Chip Quigley, founder and CEO of Kingdom Entertainment Group, and Ari Freedman, a seasoned executive from Surge Brands, to advise across the brand’s marketing and events, and brand development and distribution respectively.
Quigley brings over two decades of experience in the New York concert business, artist management space, and has extensive involvement in producing high-profile events including the Jones Beach Concert Series, EP of the International Emmy Awards, The Victoria Secret TV specials and more. Known for crafting cutting-edge marketing campaigns and activations for brands across multiple consumer categories, Quigley’s background and overarching strategic vision for Safety Shot will be invaluable in elevating the Company through innovative events and promotional initiatives.
Freedman has successfully led countless brands to achieve significant growth and market penetration through development and distribution, and brings to the table a keen eye for market trends and consumer behavior. His expertise will play a crucial part in expanding Safety Shot’s distribution channels and ensuring that the product reaches a wider audience.
“We are thrilled to partner with Chip and Ari to tap their expertise to further elevate Safety Shot’s market presence through high-profile events and marketing campaigns as well as a strategic oversight on distribution,” said Josh Wagner, Chief Revenue Officer of Safety Shot. “Their years of combined experience offer a fresh lens on the brand and bring new perspectives and growth opportunities, ultimately fast-tracking our goal to disrupt the industry with our first-of-its-kind beverage.”
This announcement comes on the heels of Safety Shot’s Northeast expansion plan and partnership with Mr. Checkout and Capital Drugs pharmacies across the United States. Additional partnerships include GoPuff, BevMo, and more.
For more information, visit www.drinksafetyshot.com.
About Safety Shot, Inc
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Media and Investor Contact:
Autumn Communications
Melissa Kanter
Phone: 201-213-3239
Email: shot@autumncommunications.com
Medon Michaelides
Investor Relations
Phone: 561-244-7100
Email: investors@drinksafetyshot.com
$AVRW Brand Ambassador Article out on @Medium "Nicole Kidman Just Turned 57, and I’m Buying Her 5 Go-To Beauty Products" via @SeralabsHealth https://www.instyle.com/nicole-kidman-birthday-favorite-beauty-products-8666305?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons via @InStyle #OTCQB @AvenirWellness
$AVRW Avenir Wellness Solutions, Inc. (OTCQB: AVRW) is undervalued at its current trading levels. Latest Sales Results Show Accelerating Strength via New Marketing Campaigns
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
$AVRW For more info , please visit: www.avenirwellness.com and www.seralabshealth.com
$SHOT 1.225 +17.14% on #NEWS @EINews- (PR) Professional Boxer and Social Media Sensation Ryan Garcia Joins Safety Shot as Brand Ambassador ESPN @joerogan Ultimate Fighting Championship Safety Shot Article! https://www.einpresswire.com/article/722420696/famed-professional-boxer-social-media-sensation-ryan-garcia-becomes-brand-ambassador-for-safety-shot-nasdaq-shot @drinksafetyshot $MNST Monster Energy #energydrinks
$ACGX Q1 2024 report is out with an 88% increase in Net Income from Q1 2023 to Q1 2024 PR at: https://otcmarkets.com/stock/ACGX/news #OTCmarkets #RealEstate #SecuredInvestments #CorporateAcquisitions #Investments #Consulting #PeopleVine #ACGX #MembershipClubs #MemberPayments #CRM https://t.co/n85aS5OcyN
$CYCA CyttaAIR Partners with FIZUAS to Dominate the American Drone Reseller and Advanced Streaming Technology Market
@CyttaCorp CEO #GaryCampbell
https://finance.yahoo.com/news/cyttaair-partners-fizuas-dominate-american-120000070.html
#CyttaCorp #TechInnovation #Leadership
$RENB In Recent NEWS, Renovaro Inc. announces $10M in equity committed https://seekingalpha.com/news/4116188-renovaro-announces-10m-in-equity-committed?source=tweet
$NRXP Retweeted: "Heat health awareness is vitally important for individuals living with a mental health condition and their loved ones."
Learn about the impacts and ways to reduce risks: https://bit.ly/4cuvjeO
Heat health awareness is vitally important for individuals living with a mental health condition and their loved ones.
— NAMI (@NAMICommunicate) June 20, 2024
Learn about the impacts and ways to reduce risks: https://t.co/DAzX0cde5r pic.twitter.com/4zbGZ4glWq
$GRLF NEWS: Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai
PR Newswire
Mon, Jun 24, 2024, 8:30 AM
In this article: GRLF
PEMBROKE PINES, Fla., June 24, 2024 /PRNewswire/ -- Green Leaf Innovations, Inc. (OTCPK: GRLF), an emerging growth company specializing in marketing and distributing handmade premium cigars, announces a major expansion in its international distributor partnerships with Le Cigaro FZ-LLC in Dubai and the UAE. Le Cigaro has selected the Cubanacan Heritage Cigar Brand under the Green Leaf Innovations umbrella as one of its signature offerings for its esteemed clientele.
Le Cigaro is renowned as the premier destination for cigar enthusiasts, offering a wide range of cigars, accessories, and wine accessories. They provide custom-made humidor cabinets with built-in humidifiers to preserve cigar quality, along with expert-led cigar training sessions.
Additionally, Le Cigaro enhances the cigar experience with personalized drink pairing recommendations and hosts live cigar rolling events for private gatherings. Their exclusive cigar agreement includes renowned hotel chains such as:
W Hotel W ABU DHABI - YAS ISLAND which caters to the FORMULA 1 ETIHAD AIRWAYS ABU DHABI GRAND PRIX 2024.
Abu Dhabi National Hotels, a chain of 16 hotels known for their exceptional hospitality.
Bvlgari Hotels & Resorts, renowned for their luxury and elegance.
The Ritz-Carlton, Dubai (ritzcarlton.com), a symbol of sophistication and luxury.
Crown Plaza Hotels, offering a blend of comfort and class.
"We are delighted that Le Cigaro has chosen our Cubanacan Heritage Cigar Brand," said Robert Mederos, CEO of Green Leaf Innovations. "This partnership and Le Cigaro's exclusive hotel agreements underscore our commitment to expanding globally and delivering premium cigar experiences in Dubai and the UAE."
About Le Cigaro FZ-LLC
Le Cigaro FZ-LLC is a premier wholesaler of cigars, cigar accessories, and wine accessories in Dubai and the UAE. Known for its exceptional range of products and services, Le Cigaro is dedicated to enhancing the cigar experience for its prestigious clients. From custom-made humidor cabinets to cigar training and live cigar rolling events, Le Cigaro provides a comprehensive and memorable cigar experience.
For more information about Le Cigaro FZ-LLC please visit www.lecigaro.com
About Green Leaf Innovations, Inc.
Green Leaf Innovations, Inc., a Florida corporation, is an emerging growth company engaged in the Marketing and Distribution of handmade premium cigars. The company strategically imports and exclusively distributes some of the best-known premium cigar brands in the Market created by the Mederos family a Third generation Cigar maker with Robert Mederos at the helm who has owned and operated handmade cigar operation in Nicaragua and the US for over 20 years with a rich family history in the craft dating back to the 1800s Cuba, brands such as CUBANACAN, MEDEROS and TABACALERA SERRANO. In addition to it the company also distributes packaged whole leaf Tobacco to cigar lounges, smoke shops, C-stores and vape shops across the United States and soon International Markets.
Additional information can be found on our websites http://www.greenleafinnovation.com or follow us on Twitter @otcgrlf.
Phone number: (800) 303-6268
Email: info@greenleafinnovation.com
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. The Company may also make written or oral forward-looking statements in its filings with the U.S. Securities and Exchange Commission, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. There can be no assurance that such statements will prove to be accurate. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company's Annual Reports on Form 10-K and its other filings with the Securities and Exchange Commission. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control. The Company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.
View original content:https://www.prnewswire.com/news-releases/green-leaf-innovations-inc-expands-international-presence-with-new-partnership-in-dubai-302180253.html
SOURCE Green Leaf Innovations, Inc.
$SHOT NEWS! "Professional Boxer and Social Media Sensation
@RyanGarcia Joins Safety Shot as Brand Ambassador"
Follow $SHOT on Twitter @drinksafetyshot
Link: https://globenewswire.com/en/news-release/2024/06/24/2902986/0/en/Professional-Boxer-and-Social-Media-Sensation-Ryan-Garcia-Joins-Safety-Shot-as-Brand-Ambassador.html
$CYCA Today's @CyttaCorp Weekly Investor Business Update is at Noon EST!! #Friday #Weekly #Updates Sign up here for the call: https://us06web.zoom.us/webinar/register/WN_OOl4wsEtR3ChyGmACKE0dg?t=1718981732580 #OTCQB
#LawEnforcement #CyttaCOMMS #DroneTechnology #PublicSafety
$NRXP Another great article on #FactoidFriday #mentalillness #mentalhealthawarenessmonth #mentalhealthmatters #bipolar #NRX101 #NRX100 $NRXP
Learn More - https://nrxpharma.com/nrx-100-nrx-101/#NRX100-101
$CYCA: Cytta Corp. Weekly Investor Business Update
Date & Time: Jun 21, 2024 12:00 PM in EDT
Description: Join Our Weekly Investor Business Update with Cytta Corp CEO, Gary Campbell as well as Cytta Corp. President, Natalia Sokalova and VP of Business Development, Mike Elliott
Date: Friday, June 21st, 2024 at 12 pm EDT
Time: 12 pm EDT
Link:
https://us06web.zoom.us/webinar/register/WN_OOl4wsEtR3ChyGmACKE0dg#/registration
Followers
|
118
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
37853
|
Created
|
07/31/17
|
Type
|
Free
|
Moderator jedijazz | |||
Assistants ProfitScout paytheask budfoxfun FrontPageStocks |
FRONT PAGE STOCKS BOARD ![yes yes](https://investorshub.advfn.com/ckeditor/plugins/smiley/images/thumbs_up.png)
Company Profiles:
Shareholder-Friendly Moves Returns 4 Million Shares of Preferred Stock to Company, Plus Equity Partnership with Coastal Spritz Brand and New Business Plans Focused on Real…
Advanced Thin Film Solar Power Technology Used in Aerospace and by NASA, Industrial/Commercial Construction and Many Consumer Goods; Reaching Record Power Generation Milestones: Ascent Solar…
Increasingly Positive Fundamentals Reported for Marketerof Best Performing Skin Care Line with Endorsements by Nicole Kidman and Top Plastic Surgeon: Avenir Wellness Solutions, Inc. (Stock…
New European Supply Chain Center to Enhance Global Growth of Interconnected Products Needed in a Wide Range of Industries: CCSC Technology International Holdings Limited (Nasdaq:…
Clinical Trials Commenced for Promising Acclaim-3 Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer: Genprex, Inc. (NASDAQ: GNPX)GNPX in combination…
Expanding Prospects Ahead for Nicaragua Imported Handmade Premium Cigar Business Backed by Strong Family History and Experience: Green Leaf Innovations, Inc (Stock Symbol: GRLF).For additional…
Cross-Licensing Agreement with I4F to Expand Business Strategies for 3D Printed Ecosystem Flooring and Wall Pannel Products Made with Recycled Ocean Plastics: Northann Corp (NYSE:…
Trial Endpoint Reached for First Suicidal Bipolar Depression, Chronic Pain and PTSD Drug; Agreement with Partners Can Provide up to $329 Million and Royalties: NRx…
Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB)$RENB is Working…
AI Education Provider Plans for New Facilities and Enters Agreement with Top 500 Company in China to Establish Life Sciences Conglomerate in Toronto: Visionary Holdings…
Establish Life Sciences Conglomerate in Toronto: Visionary Holdings…
We believe in building long lasting relationships as noted by our vast amount of real, contactable clients hat span over 2 decades!
This helps individual investors to investigate compelling investments.
We are a link between small public companies and the investing public. The company’s plans, profiles and information are written with the individual investor in mind.
Our goal is to explain the complex, reduce the jargon, and provide a clear and engaging story of each company’s strategy and growth potential.
Bringing you this information requires our staff to work closely with each featured company, as we are small cap stock investors ourselves.
We want what you want – an understanding of what the company does, how they make money and how they intend to grow with frequent company updates.
Small cap investing is unlike buying shares of an S&P 500 company. It is generally a longer term commitment that generates an emotional link with the company.
An understanding of opportunity and the company plan generate the interest. Continued updates and information provide the basis for a satisfied and supportive investor base.
Here at Front Page Stocks, we understand that relationship ultimately closing the gap between investor and company.
We promise to present to you engaging, real companies with real products and services. We hope they will captivate and excite you in return.
Posts Today
|
0
|
Posts (Total)
|
37853
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |